Max India Past Earnings Performance
Past criteria checks 0/6
Max India has been growing earnings at an average annual rate of 18.4%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been growing at an average rate of 7.8% per year.
Key information
18.4%
Earnings growth rate
12.2%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 7.8% |
| Return on equity | -7.4% |
| Net Margin | -19.1% |
| Next Earnings Update | 24 May 2024 |
Recent past performance updates
Recent updates
There's Reason For Concern Over Max India Limited's (NSE:MAXIND) Price
Apr 27
Max India Limited's (NSE:MAXINDIA) Business Is Yet to Catch Up With Its Share Price
Dec 27Returns At Max India (NSE:MAXIND) Are On The Way Up
Aug 02Pinning Down Max India Limited's (NSE:MAXIND) P/S Is Difficult Right Now
Jun 01A Look At The Fair Value Of Max India Limited (NSE:MAXIND)
Apr 25Revenue & Expenses BreakdownBeta
How Max India makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,044 | -390 | 782 | 0 |
| 30 Sep 23 | 2,060 | -214 | 739 | 0 |
| 30 Jun 23 | 2,120 | -184 | 694 | 0 |
| 31 Mar 23 | 2,126 | -104 | 611 | 0 |
| 31 Dec 22 | 2,023 | -92 | 661 | 0 |
| 30 Sep 22 | 1,990 | -142 | 630 | 0 |
| 30 Jun 22 | 2,233 | -125 | 610 | 0 |
| 31 Mar 22 | 2,346 | -161 | 652 | 0 |
| 31 Dec 21 | 2,162 | -260 | 695 | 0 |
| 30 Sep 21 | 2,072 | -332 | 797 | 0 |
| 30 Jun 21 | 1,507 | -500 | 844 | 0 |
| 31 Mar 21 | 1,238 | -531 | 973 | 0 |
| 31 Dec 20 | 1,597 | -360 | 907 | 0 |
| 30 Sep 20 | 1,610 | -803 | 907 | 0 |
| 30 Jun 20 | 1,711 | -696 | 920 | 0 |
| 31 Mar 20 | 1,831 | -232 | 951 | 0 |
| 31 Mar 19 | 1,567 | -65 | 914 | 0 |
| 31 Mar 18 | 2,423 | -760 | 862 | 0 |
| 31 Mar 17 | 14,320 | -540 | 4,363 | 0 |
| 31 Mar 16 | 9,790 | -646 | 3,112 | 0 |
Quality Earnings: MAXIND is currently unprofitable.
Growing Profit Margin: MAXIND is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MAXIND is unprofitable, but has reduced losses over the past 5 years at a rate of 18.4% per year.
Accelerating Growth: Unable to compare MAXIND's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MAXIND is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (28%).
Return on Equity
High ROE: MAXIND has a negative Return on Equity (-7.36%), as it is currently unprofitable.